Pfizer Beats Q1 Wall Street Estimates; Sees COVID-19 Vaccine Sales Of $26B In FY21
May 04, 2021 at 10:57 AM EDT
Pfizer Inc reported Q1 sales of $14.6 billion up 45% Y/Y, beating a consensus of $13.6 billion. It saw a 3% favorable impact of foreign exchange.